Anixa Biosciences has achieved a significant milestone in its quest to develop a preventive vaccine for breast cancer, securing a…
Read More
INTEGRA Biosciences Automates Quantabio sparQ DNA Frag & Library Prep Kit Workflow, Enhancing NGS Efficiency and Reproducibility
Zizers, Switzerland / Beverly, MA – INTEGRA Biosciences, a leading provider of high-quality laboratory tools for liquid handling and media…
Read More
Protuoso Biosciences Secures $9.5 Million Seed Funding to Pioneer Multifunctional Biologics for Complex Diseases
Protuoso Biosciences, a burgeoning US-based biotechnology company, has successfully closed a $9.5 million seed financing round, positioning itself to revolutionize…
Read More
Teva Pharmaceuticals Acquires Emalex Biosciences for $700 Million to Bolster Neurology Pipeline and Drive Growth Strategy
Teva Pharmaceuticals is set to significantly expand its presence in the neuroscience market with the acquisition of Emalex Biosciences, a…
Read More
Terremoto Biosciences Secures $108 Million Series C to Advance Next-Generation AKT1 Inhibitors for Oncology and Rare Diseases
Terremoto Biosciences, a pioneering biotechnology company at the forefront of developing novel therapeutics targeting the PI3K/AKT pathway, announced today the…
Read MoreYOU MAY HAVE MISSED
